Morgan Stanley’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Buy |
|
|||||
|
2025
Q1 | $2.58M | Sell |
|
|||||
|
2024
Q4 | $2.45M | Sell |
|
|||||
|
2024
Q3 | $3.44M | Sell |
|
|||||
|
2024
Q2 | $3.99M | Sell |
|
|||||
|
2024
Q1 | $5.03M | Sell |
|
|||||
|
2023
Q4 | $11.1M | Buy |
|
|||||
|
2023
Q3 | $2.02M | Buy |
|
|||||
|
2023
Q2 | $1.82M | Buy |
|
|||||
|
2023
Q1 | $1.51M | Sell |
|
|||||
|
2022
Q4 | $5.64M | Buy |
|
|||||
|
2022
Q3 | $448K | Sell |
|
|||||
|
2022
Q2 | $584K | Sell |
|
|||||
|
2022
Q1 | $993K | Buy |
|
|||||
|
2021
Q4 | $835K | Buy |
|
|||||
|
2021
Q3 | $300K | Buy |
|
|||||
|
2021
Q2 | $235K | Sell |
|
|||||
|
2021
Q1 | $766K | Buy |
|
|||||
|
2020
Q4 | $233K | Buy |
|
|||||
|
2020
Q3 | $63K | Sell |
|
|||||
|
2020
Q2 | $75K | Sell |
|
|||||
|
2020
Q1 | $151K | Buy |
|
|||||
|
2019
Q4 | $337K | Sell |
|
|||||
|
2019
Q3 | $444K | Buy |
|
|||||
|
2019
Q2 | $21K | Sell |
|
|||||
|
2019
Q1 | $214K | Buy |
|
|||||
|
2018
Q4 | $17K | Sell |
|
|||||
|
2018
Q3 | $93K | Buy |
|
|||||
|
2018
Q2 | $6K | Buy |
|
|||||
|
2018
Q1 | $0 | Hold |
|
|||||
|
2017
Q4 | $0 | Hold |
|
|||||
|
2017
Q3 | $0 | Sell |
|
|||||
|
2017
Q2 | $1K | Hold |
|
|||||
|
2017
Q1 | $1K | Hold |
|
|||||
|
2016
Q4 | $1K | Sell |
|
|||||
|
2016
Q3 | $1K | Sell |
|
|||||
|
2016
Q2 | $8K | Buy |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $22K | Sell |
|
|||||
|
2015
Q3 | $23K | Buy |
|
|||||
|
2015
Q2 | $38K | Buy |
|